Dolomite Announces Microdroplet IP License Arrangements with JST
News Aug 24, 2012
Dolomite has announced that it is now a licensee of Japan Science and Technology Agency (“JST”) under JST’s microdroplet generation technology.
Dolomite is authorized to grant sublicenses under JST’s microdroplet generation technologies.
Dolomite offers a wide range of Droplet-forming devices featuring different junction geometries, channel sizes and surface properties.
Droplet based microfluidics is ideal for a wide range of applications, including compartmentalized chemistry, single cell analysis, high throughput screening, droplet PCR and emulsion studies.
As a licensee of JST's microdroplet generation technology patent families WO2002/068104 and WO2005/089921, our customers may purchase and freely use Dolomite droplet chips for R&D purposes.
As part of the IP agreement, Dolomite is authorized to grant sub-licenses under JST’s microdroplet generation technologies.
Through the innovative use of our web shop, end-users can obtain sub-licenses very simply, using only a credit card.
Licenses are issued on a per chip basis, and may be purchased in any quantity from one to one million.
Dolomite CEO Andrew Lovatt commented: “We are very pleased to be able to offer this IP-licensing service to our clients, enabling them to continue with their droplet research free from concerns about violating this fundamental IP”.
Novel Green Chemistry Method Improves Pharmaceutical Manufacturing EfficiencyNews
About 70 percent of pharmaceuticals are manufactured using palladium-driven catalytic processes that are either fast or efficient - but not both. Researchers have now developed a green chemistry method that combines aspects of both processes to improve efficiency at a minimal cost of processing time.READ MORE
Radioprotective Drugs Assessed Using Human Gut Organ-on-a-ChipNews
Researchers have published a study using an organ-on-a-chip (Organ Chip) model of the human gut that reveals the intestinal blood vessel cells may play an important part in radiation-induced intestinal injury, and it confirms that a potential radioprotective drug, dimethyloxaloylglycine (DMOG), suppresses the intestine’s responses to radiation injury.READ MORE
From Human Biopsy to Complex Gut Physiology on a ChipNews
Organ Chip technology using donor-derived human intestinal cells offers advantages over organoids and creates new opportunities for personalized medicine.READ MORE
Comments | 0 ADD COMMENT
Next Gen Regenerative Medicine & Tissue Engineering
May 29 - May 30, 2018